Diagnosis Of Autism Spectrum Disorders (ASD) Is currently based On Psychological And Behavioral Evaluations

These tests:

  • can not be performed on infants and very young children below 18 months of age
  • require social and language skills
  • require child cooperation
  • are time-consuming and expensive.

Yet early signs of ASD are often apparent at the infant stage of development, including lack of eye movement, smiles and response to the environment. If at this stage, a simple blood test was available to objectively diagnose ASD, earlier clinical therapeutic intervention would be possible and more likely to be successful due to brain plasticity of the developing child.

Research: Search for Biomarkers to Identify ASD Patients

Cell-El is working to identify blood-borne, ASD-specific diagnostic markers. Using proteomics our initial analysis of a broad panel of serum proteins has identified  a pattern of biomarkers that can be used to discriminate between typically developed (TD) children and those on the autism spectrum. 

Read more about our scientific method and published research:

Make a Difference

By having your child or patient participate in Cell-El’s diagnostic research, you can make a difference to the future therapies available for ASD.

  • Fill out the appropriate form under Join Our Team in the column to the right
  • A phone screening with Leah (approximately 5  minutes)
  • A simple blood test where 5 ml of blood will be drawn
  • Filling out a family medical history questionnaire (about 20 minutes)

We look forward to your participation in the Cell-El diagnostic study. Please read the information below regarding the inclusion and exclusion criteria for the following cohorts: Infants and their mothers and Stem Cell Therapy (SCT). Then please fill out the appropriate form.

  • Cohort of infants and their mothers: Mothers of high-risk infants and infants aged 10-18 months not diagnosed with ASD but with a sibling diagnosed with ASD according to Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV (299.00) or DSM-V (299.00) ± ADOS (herein termed “high-risk infants”) or
  • Cohort of children pre and post SCT: Male and female children age 2-12 years Diagnosed autism spectrum disorder (ASD) according to Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV (299.00) or DSM-V (299.00) undergoing stem cell therapy.
  • For both cohorts: Informed consent signed by the parents
  • For both cohorts: Child and/or mother that have been treated with systemic steroids or have undergone immune suppression treatment within the last 6 months
  • Child and/or mother diagnosed with severe infectious diseases or sepsis over the last 6 months
  • Child and/or mother with hematological or malignant disorder
  • For children in the SCT cohort: No new planned treatment (other than SCT) for at least 6 months from planned stem cell transplantation date and no new treatments (other than SCT) started within 6 months before planned transplantation date.
  • Child with ASD treated for a severe convulsive disorder

Join Our Team

Thank you for taking the next step in joining Cell-El and finding a biological therapy for ASD. Please fill out the appropriate form below and we will contact you.

If you are a parent of a child diagnosed with ASD, please fill out the form below.

    I am interested in taking part in the

    Yes! I would like to subscribe to the Cell-El mailing list


    If you do not see a thank you message after pressing send you have not filled in all the required fields. Please review your form and fill in the missing information, otherwise, your form will not be sent.

    If you are a clinician treating children diagnosed with ASD, please fill out the form below.


      I am interested in finding out more about the

      Yes! I would like to subscribe to the Cell-El mailing list

      If you do not see a thank you message after pressing send you have not filled in all the required fields. Please review your form and fill in the missing information, otherwise, your form will not be sent.

        Yes! I would like to subscribe to the Cell-El mailing list